WO2018225898A1 - Lifting member - Google Patents

Lifting member Download PDF

Info

Publication number
WO2018225898A1
WO2018225898A1 PCT/KR2017/011108 KR2017011108W WO2018225898A1 WO 2018225898 A1 WO2018225898 A1 WO 2018225898A1 KR 2017011108 W KR2017011108 W KR 2017011108W WO 2018225898 A1 WO2018225898 A1 WO 2018225898A1
Authority
WO
WIPO (PCT)
Prior art keywords
mesh
net
lifting member
central yarn
coupled
Prior art date
Application number
PCT/KR2017/011108
Other languages
French (fr)
Korean (ko)
Inventor
김근식
Original Assignee
주식회사 동방메디컬
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 동방메디컬 filed Critical 주식회사 동방메디컬
Publication of WO2018225898A1 publication Critical patent/WO2018225898A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059Cosmetic or alloplastic implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • A61F2002/0068Implantable repair or support meshes, e.g. hernia meshes having a special mesh pattern

Definitions

  • the present invention relates to a lifting member.
  • Native substances are present in the muscle fibers that make up the muscles of the human body. And when foreign matter enters the muscle, foreign substances gather around the foreign matter to protect the muscle against the foreign matter. The native substance is produced to protect the muscle, but consequently strengthens the muscle.
  • the wounded area transmits information that needs to be regenerated or regulated through the nerve to the nerve center, and promotes a combination of specific biochemicals present in the body to enhance the body's immune function through activation of the body's fluid circulation and body-related books. Regulates the function and strengthens the muscles.
  • the present invention provides a lifting member that can broaden the cross-sectional area in contact with the body to improve the production of native materials.
  • the lifting member according to the present invention comprises: a first mesh extending in one direction and having a fixed end at one end thereof; And a second mesh located inside the first mesh and coupled to the fixed end.
  • the second mesh may extend along the longitudinal direction of the first mesh.
  • the first mesh may be formed in the form of a tube having a first diameter
  • the second mesh may be formed in the form of a tube having a second diameter smaller than the first diameter
  • the second net may be made of at least one.
  • the first and second meshes include polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL), polydioxanone (PDO), It may be formed through any one selected from gold or a combination thereof.
  • PGA polyglycolide
  • PLA polylactic acid
  • PLLA poly-L-lactide
  • PCL polycaprolactone
  • PDO polydioxanone
  • the lifting member according to the present invention includes a central yarn extending in one direction; A first mesh coupled to one side of the central yarn and extending in a longitudinal direction of the central yarn; And a second net coupled to the other side of the central yarn and extending in the longitudinal direction of the central yarn.
  • the first net may extend in one direction from one side of the central yarn
  • the second net may extend in one direction from the other side of the central yarn
  • the first mesh may be formed in the form of a tube having a first diameter
  • the second mesh may be formed in the form of a tube having a second diameter smaller than the first diameter
  • the second net may be made of at least one.
  • At least a portion of the second net may be located inside the first net.
  • the second net may be spaced apart from the first net.
  • Lifting member according to an embodiment of the present invention is made of a double mesh structure including a first mesh and a second mesh, it is possible to increase the effect of generating a native material by widening the cross-sectional area in contact with the body. Accordingly, the present invention can enhance the therapeutic or cosmetic effect.
  • FIG. 1 is a cross-sectional view showing a lifting member according to an embodiment of the present invention.
  • FIGS. 2A and 2B are enlarged cross-sectional views illustrating a lifting member according to an embodiment of the present invention.
  • FIG 3 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • FIG. 4 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • FIG. 5 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • FIG. 6 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • FIG. 1 is a cross-sectional view showing a lifting member according to an embodiment of the present invention.
  • 2A and 2B are enlarged cross-sectional views illustrating a lifting member according to an embodiment of the present invention.
  • the lifting member 100 according to an embodiment of the present invention includes a first mesh 110 and a second mesh 120.
  • the lifting member 100 may be inserted into the human body through the needle 10 to induce the production of native substances, thereby exhibiting a therapeutic or cosmetic effect.
  • the first net 110 is formed long in one direction, it is provided in the form of a tube having a first diameter. Since the first mesh 110 has a plurality of holes, body fluids such as blood may move through the holes even when inserted into the human body. In addition, the shape of the first mesh 110 formed with a plurality of holes may be referred to as a mesh shape. In addition, since the first mesh 110 can secure the maximum cross-sectional area that can be contacted in the human body, it is possible to increase the effect of generating a native material.
  • the first mesh 110 may be made of a material that is harmless to the human body, and if it remains in the body, it may be removed by melting over time.
  • the material of the first mesh 110 is polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL), polydioxane It may be formed through any one selected from the group consisting of PDO, gold, or a combination thereof.
  • a fixed end 111 is formed at one end of the first mesh 110.
  • the fixing end 111 may form one end of the first mesh 110 in a form bonded to each other by a thermocompression bonding method.
  • the fixed end 111 is removed from the body together with the needle 10 when the lifting member 100 is inserted into the body through the needle 10 and then the needle 10 is removed. Serves to prevent this from happening.
  • the fixing end 111 serves to fix the position of the lifting member 100 in the body.
  • the second mesh 120 is located inside the first mesh 110 and is provided in the form of a tube which is formed to be long in one direction and has a second diameter.
  • the second mesh 120 is formed to have the same length as the first mesh 110 but has a second diameter smaller than the first diameter of the first mesh 110.
  • the second mesh 120 is formed more densely than the first mesh 110.
  • One end of the second mesh 120 is coupled to the fixed end 111 of the first mesh 110.
  • one end of the second mesh 120 may be coupled to the fixed end 111 by a thermal compression method. Therefore, even if the needle 10 is removed after the lifting member 100 is inserted into the body through the needle 10, the second mesh 120 remains in the body coupled to the first mesh 110. do.
  • the second mesh 120 can increase the cross-sectional area that can be contacted in the human body, it is possible to increase the effect of generating a native material.
  • the second mesh 120 may be made of a material that is harmless to the human body, and if it remains in the body, it may be removed by melting over time.
  • the material of the second mesh 120 is the same as the first mesh 110, polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), Polycaprolactone (PCL), polydioxanone (PDO), gold may be formed through any one or a combination thereof.
  • the first mesh 110 is located outside the needle 10 and the second mesh 120 is the needle 10. It may be located inside of. That is, the needle 10 is fitted between the first mesh 110 and the second mesh 120, one end of the needle 10 is coupled to the fixed end 111.
  • the lifting member 100 is coupled to the needle 10 and inserted into the body. As the needle 10 is removed, only the lifting member 100 remains in the body.
  • the needle 10 may insert the lifting member 100 into the body while being coupled to a syringe or the like, and receive the drug or the like from the syringe and inject it into the human body through the lifting member 100.
  • the lifting member 100 has a double mesh structure (having a first mesh and a second mesh), thereby widening the cross-sectional area that can be contacted in the body, thereby generating a native material. Can increase. Accordingly, the lifting member 100 according to an embodiment of the present invention can improve the therapeutic or cosmetic effect.
  • FIG 3 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • the lifting member 200 includes a first mesh 110 and a second mesh 220. Portions having the same configuration and operation as those of the above-described embodiment are denoted by the same reference numerals, and hereinafter, the differences from the previous embodiment will be mainly described.
  • the second mesh 220 is located inside the first mesh 110 and is provided in the form of a tube elongated in one direction.
  • the second net 220 is made of a plurality, is formed to be the same as the length of the first net (110).
  • the second mesh 220 is illustrated as two, but the second mesh 220 may be formed in more than one.
  • the diameter of the second meshes 220 becomes smaller.
  • one end of the second mesh 220 is coupled to the fixed end 111 of the first mesh 110.
  • one end of the second net 220 may be coupled to the fixed end 111 by a thermocompression method. Therefore, even if the needle 10 is removed after the lifting member 200 is inserted into the body through the needle 10, the second mesh 220 remains in the body coupled to the first mesh 110. do.
  • the lifting member 200 includes the first mesh 110 and the plurality of second meshes 220, thereby increasing the cross-sectional area in contact with the body to induce more native substances. can do.
  • FIG. 4 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • the lifting member 300 includes a first mesh 110, a second mesh 220, and a central yarn 330.
  • the central yarn 330 is located inside the first mesh 110, and is formed to be elongated in a straight line along the longitudinal direction of the first mesh 110.
  • One end of the central yarn 330 is coupled to the fixed end 111 of the first mesh 110. That is, the center yarn 330 is located at the center of the first mesh 110, one end is coupled to the fixed end 111 and extends in a straight line along the longitudinal direction of the first mesh 110.
  • one end of the first mesh 110 is coupled to the central yarn 330 by a thermal compression method, the fixed end 111 may be formed.
  • the material of the core yarn 330 is polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL) as in the first mesh 110 ), Polydioxanone (PDO), gold, or any combination thereof.
  • PGA polyglycolide
  • PLA polylactic acid
  • PLLA poly-L-lactide
  • PCL polycaprolactone
  • PDO Polydioxanone
  • the second mesh 320 is located inside the first mesh 110 and is coupled to the central yarn 330.
  • the second net 320 is made of a plurality, it is formed shorter than the length of the first net (110).
  • a coupling part 321 fixed to the central yarn 330 is formed at one end of the second mesh 320.
  • the coupling part 321 may be formed by fixing one end of the second mesh 320 to the central yarn 330 by a thermocompression bonding method. That is, the second mesh 320 is formed to be shorter than the length of the first mesh 110, a plurality of which is located inside the first mesh 110 while being coupled to the central yarn 330.
  • the second mesh 320 extends in a direction opposite to the extending direction of the first mesh 110.
  • the first mesh 110 is coupled to one side of the central yarn 330 and extends from one side to the other side, while the second mesh 320 is Is coupled to the other side of the central yarn 330 is formed to extend in one direction from the other side.
  • the lifting member 300 When the lifting member 300 is inserted into the body, a part of the central yarn 330 is exposed to the outside. Then, even if a person pulls the central yarn 330 from the outside, the first net 110 and the second net 320 is not pulled by the resistance in the body and remain more dense form. Thus, it is possible to induce the production of more native substances in certain parts.
  • FIG. 5 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • the lifting member 400 includes a first mesh 410, a second mesh 420, and a central yarn 330.
  • the first net 410 is coupled to one end of the central yarn 330, is formed to extend in one direction from one side of the central yarn 330.
  • One end of the first mesh 410 is formed with a fixed end 411 is coupled to the central yarn 330.
  • the first mesh 410 is formed in a relatively short length compared to the first mesh 110 shown in FIG.
  • the second net 420 is coupled to the other side of the central yarn 330, is formed to extend in one direction from the other side of the central yarn 330. That is, the second mesh 420 extends in the direction opposite to the extending direction of the first mesh 410.
  • One end of the second net 420 is formed with a coupling portion 421 is fixedly coupled to the central yarn 330.
  • the second mesh 420 is formed to be spaced apart from the first mesh 410. In other words, the diameter of the second mesh 420 is smaller than the diameter of the first mesh 410, but is not located inside the first mesh 410.
  • FIG. 6 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
  • the lifting member 500 includes a first mesh 410, a second mesh 520, and a central yarn 330.
  • the second net 520 is coupled to the other side of the central yarn 330, is formed to extend in one direction from the other side of the central yarn 330.
  • One end of the second net 520 is formed with a coupling portion 521 fixedly coupled to the central yarn 330. That is, the second mesh 520 extends in the direction opposite to the extending direction of the first mesh 410. In addition, a portion of the second mesh 520 is formed to overlap with the first mesh 410.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a lifting member enabling the enhancement of autogenous material generation by enabling a cross-sectional area making contact with the interior of the human body to be widened. According to one embodiment, disclosed is a lifting member comprising: a first mesh extending in one direction and having a fixing end part formed on one end thereof; and a second mesh positioned on the inner side of the first mesh and coupling to the fixing end part.

Description

리프팅 부재Lifting member
본 발명은 리프팅 부재에 관한 것이다.The present invention relates to a lifting member.
인체의 근육을 이루는 근육 섬유 내에는 자생 물질이 존재한다. 그리고 근육 내에 이물질이 들어가면 이물질 둘레에 자생 물질이 모여들어 침범한 이물질에 대해 근육을 보호한다. 상기 자생 물질은 근육을 보호하기 위해 생성된 것이지만 결과적으로 근육을 강화시킨다.Native substances are present in the muscle fibers that make up the muscles of the human body. And when foreign matter enters the muscle, foreign substances gather around the foreign matter to protect the muscle against the foreign matter. The native substance is produced to protect the muscle, but consequently strengthens the muscle.
이러한 자생 물질에는 매우 많은 종류가 있다. 이는 피부의 일부 근육조직에 인위적으로 상처를 주었을 때 상처받은 조직세포에서 방출하며 조직에 일련의 생리적 변화를 가져오는 화학인자로서 상처를 회복시키는 조건을 제공한다. 생물전기학과 압전기학 및 생물범제어론의 원리에 근거하여 보다 구체적으로 말하자면, 상기 화학인자는 열에너지로 변화하여 작은 혈관을 확장하고 림프(lymph)의 순환을 가속화하여 신진 대사 능력을 크게 높이며 해당 부위의 영양공급을 강화할 뿐만 아니라 체액순환을 통해 병적생성물을 제거하고 동시에 일부 조직의 단백질을 분해하고 말초신경 체질(遞質)을 증가하며 혈관신경에 활성물질을 생성시켜 혈청에서의 펩타이드와 5-히드록실아민의 함량을 낮춘다. 이에 따라 상처받은 부위가 신경을 통해 재생 또는 조절해야 하는 정보를 신경중추에 전달하고 체내에 존재하는 특정한 생물화학적 물질의 조합을 빨리 추진하여 체액순환의 활성화를 통해 인체 면역기능을 제고시키며 신체관련 장부의 기능을 조절하고 근육도 강화시키게 된다.There are many different kinds of these native substances. It is a chemical factor that releases from wounded tissue cells when it artificially injures some muscle tissue of the skin and brings a series of physiological changes to the tissue, providing conditions for healing the wound. More specifically, based on the principles of bioelectricity, piezoelectricity and biogeneral control theory, the chemical factor is transformed into thermal energy to expand small blood vessels, accelerate the circulation of lymph and greatly increase metabolic capacity In addition to enhancing the nutritional supply of nutrients, body fluids can remove pathogens, at the same time decompose proteins in some tissues, increase peripheral nerve constitution, and produce active substances in the blood vessels. Lower the content of loxylamine. As a result, the wounded area transmits information that needs to be regenerated or regulated through the nerve to the nerve center, and promotes a combination of specific biochemicals present in the body to enhance the body's immune function through activation of the body's fluid circulation and body-related books. Regulates the function and strengthens the muscles.
본 발명은 체내와 접촉하는 단면적을 넓혀 자생 물질의 생성을 향상시킬 수 있는 리프팅 부재를 제공한다.The present invention provides a lifting member that can broaden the cross-sectional area in contact with the body to improve the production of native materials.
본 발명에 의한 리프팅 부재는 일 방향으로 연장되고 일단에 고정 단부가 형성된 제 1 그물망; 및 상기 제 1 그물망의 내측에 위치하고, 상기 고정 단부에 결합된 제 2 그물망을 포함하는 것을 특징으로 한다.The lifting member according to the present invention comprises: a first mesh extending in one direction and having a fixed end at one end thereof; And a second mesh located inside the first mesh and coupled to the fixed end.
상기 제 2 그물망은 상기 제 1 그물망의 길이 방향을 따라 연장될 수 있다.The second mesh may extend along the longitudinal direction of the first mesh.
상기 제 1 그물망은 제1직경을 갖는 관의 형태로 형성되고, 상기 제 2 그물망은 상기 제1직경보다 작은 제2직경을 갖는 관의 형태로 형성될 수 있다.The first mesh may be formed in the form of a tube having a first diameter, and the second mesh may be formed in the form of a tube having a second diameter smaller than the first diameter.
상기 제 2 그물망은 적어도 하나 이상으로 이루어질 수 있다.The second net may be made of at least one.
상기 제 1 그물망 및 제 2 그물망은 폴리글리골라이드(PGA), 폴리락틱액시드(PLA), 폴리-L-락타이드(PLLA), 폴리카프로락톤(PCL), 폴리다이옥사논(PDO), 금 중에서 선택된 어느 하나 또는 이들의 조합을 통해 형성될 수 있다.The first and second meshes include polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL), polydioxanone (PDO), It may be formed through any one selected from gold or a combination thereof.
또한, 본 발명에 따른 리프팅 부재는 일 방향으로 연장된 중심사; 상기 중심사의 일측에 결합되며, 상기 중심사의 길이 방향을 따라 연장된 제 1 그물망; 및 상기 중심사의 타측에 결합되며, 상기 중심사의 길이 방향을 따라 연장된 제 2 그물망을 포함하는 것을 특징으로 한다.In addition, the lifting member according to the present invention includes a central yarn extending in one direction; A first mesh coupled to one side of the central yarn and extending in a longitudinal direction of the central yarn; And a second net coupled to the other side of the central yarn and extending in the longitudinal direction of the central yarn.
상기 제 1 그물망은 상기 중심사의 일측에서 타측 방향으로 연장되고, 상기 제 2 그물망은 상기 중심사의 타측에서 일측 방향으로 연장될 수 있다.The first net may extend in one direction from one side of the central yarn, the second net may extend in one direction from the other side of the central yarn.
상기 제 1 그물망은 제1직경을 갖는 관의 형태로 형성되고, 상기 제 2 그물망은 상기 제1직경보다 작은 제2직경을 갖는 관의 형태로 형성될 수 있다.The first mesh may be formed in the form of a tube having a first diameter, and the second mesh may be formed in the form of a tube having a second diameter smaller than the first diameter.
상기 제 2 그물망은 적어도 하나 이상으로 이루어질 수 있다.The second net may be made of at least one.
상기 제 2 그물망의 적어도 일부는 상기 제 1 그물망의 내측에 위치할 수 있다.At least a portion of the second net may be located inside the first net.
상기 제 2 그물망은 상기 제 1 그물망과 이격될 수 있다.The second net may be spaced apart from the first net.
본 발명의 일 실시예에 따른 리프팅 부재는 제 1 그물망 및 제 2 그물망을 포함하는 이중 그물망 구조로 이루어짐으로써, 체내와 접촉하는 단면적을 넓혀 자생 물질이 생성되는 효과를 높일 수 있다. 이에 따라, 본 발명은 치료 또는 미용 효과를 향상시킬 수 있다. Lifting member according to an embodiment of the present invention is made of a double mesh structure including a first mesh and a second mesh, it is possible to increase the effect of generating a native material by widening the cross-sectional area in contact with the body. Accordingly, the present invention can enhance the therapeutic or cosmetic effect.
도 1은 본 발명의 일 실시예에 따른 리프팅 부재를 도시한 단면도이다. 1 is a cross-sectional view showing a lifting member according to an embodiment of the present invention.
도 2a 및 도 2b는 본 발명의 일 실시예에 따른 리프팅 부재를 도시한 확대 단면도이다.2A and 2B are enlarged cross-sectional views illustrating a lifting member according to an embodiment of the present invention.
도 3은 본 발명의 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다.3 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 4는 본 발명의 또 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다.4 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 5는 본 발명의 또 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다.5 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 6은 본 발명의 또 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다.6 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
이하, 첨부된 도면을 참조하여 본 발명의 바람직한 실시예를 상세히 설명하기로 한다.Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings.
본 발명의 실시예들은 당해 기술 분야에서 통상의 지식을 가진 자에게 본 발명을 더욱 완전하게 설명하기 위하여 제공되는 것이며, 하기 실시예는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 오히려, 이들 실시예는 본 개시를 더욱 충실하고 완전하게 하고, 당업자에게 본 발명의 사상을 완전하게 전달하기 위하여 제공되는 것이다.The embodiments of the present invention are provided to more fully explain the present invention to those skilled in the art, and the following examples can be modified in various other forms, and the scope of the present invention is It is not limited to an Example. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the inventive concept to those skilled in the art.
또한, 이하의 도면에서 각 구성요소의 크기는 설명의 편의 및 명확성을 위하여 과장 또는 축소된 것이며, 도면상에서 동일 부호는 동일한 요소를 지칭한다. 본 명세서에서 사용된 바와 같이, 용어 "및/또는"은 해당 열거된 항목 중 어느 하나 및 하나 이상의 모든 조합을 포함한다. 또한, 본 명세서에서 "연결된다"라는 의미는 A 부재와 B 부재가 직접 연결되는 경우뿐만 아니라, A 부재와 B 부재의 사이에 C 부재가 개재되어 A 부재와 B 부재가 간접 연결되는 경우도 의미한다.In addition, in the drawings, the size of each component is exaggerated or reduced for convenience and clarity of description, the same reference numerals in the drawings refer to the same elements. As used herein, the term "and / or" includes any and all combinations of one or more of the listed items. In addition, the term "connected" in this specification means not only the case where the A member and the B member are directly connected, but also the case where the A member and the B member are indirectly connected by interposing the C member between the A member and the B member. do.
본 명세서에서 사용된 용어는 특정 실시예를 설명하기 위하여 사용되며, 본 발명을 제한하기 위한 것이 아니다. 본 명세서에서 사용된 바와 같이, 단수 형태는 문맥상 다른 경우를 분명히 지적하는 것이 아니라면, 복수의 형태를 포함할 수 있다. 또한, 본 명세서에서 사용되는 경우 "포함한다(comprise, include)" 및/또는 "포함하는(comprising, including)"은 언급한 형상들, 숫자, 단계, 동작, 부재, 요소 및/또는 이들 그룹의 존재를 특정하는 것이며, 하나 이상의 다른 형상, 숫자, 동작, 부재, 요소 및 /또는 그룹들의 존재 또는 부가를 배제하는 것이 아니다.The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms "a", "an" and "the" may include the plural forms as well, unless the context clearly indicates otherwise. Also, as used herein, "comprise, include" and / or "comprising, including" means that the features, numbers, steps, actions, members, elements, and / or groups thereof mentioned. It is intended to specify the existence and not to exclude the presence or addition of one or more other shapes, numbers, operations, members, elements and / or groups.
도 1은 본 발명의 일 실시예에 따른 리프팅 부재를 도시한 단면도이다. 도 2a 및 도 2b는 본 발명의 일 실시예에 따른 리프팅 부재를 도시한 확대 단면도이다. 1 is a cross-sectional view showing a lifting member according to an embodiment of the present invention. 2A and 2B are enlarged cross-sectional views illustrating a lifting member according to an embodiment of the present invention.
도 1 내지 도 2b을 참조하면, 본 발명의 일 실시예에 따른 리프팅 부재(100)는 제 1 그물망(110) 및 제 2 그물망(120)을 포함한다. 이러한 리프팅 부재(100)는 니들(10)을 통해 인체 내에 삽입되어 자생 물질의 생성을 유도함으로써, 치료 또는 미용 효과를 나타낼 수 있다. 1 to 2B, the lifting member 100 according to an embodiment of the present invention includes a first mesh 110 and a second mesh 120. The lifting member 100 may be inserted into the human body through the needle 10 to induce the production of native substances, thereby exhibiting a therapeutic or cosmetic effect.
상기 제 1 그물망(110)은 일 방향으로 길게 형성되며, 제1직경을 갖는 관의 형태로 구비된다. 상기 제 1 그물망(110)은 다수의 홀이 형성되어 있으므로, 인체 내 삽입이 되더라도 상기 홀을 통해 혈액 등 체액이 이동할 수 있다. 더불어, 이와 같이 다수의 홀이 형성된 제 1 그물망(110)의 형태를 메쉬 형상이라고 부르기도 한다. 또한, 상기 제 1 그물망(110)은 사람의 체내에서 접촉할 수 있는 단면적을 최대한으로 확보할 수 있기 때문에, 자생 물질이 생성되는 효과를 높일 수 있다. 상기 제 1 그물망(110)은 인체에 무해한 재질로 이루어질 수 있으며, 체내에 잔존하게 되는 경우 일정 시간이 지남에 따라 녹아서 제거될 수 있다. 예를 들어, 상기 제 1 그물망(110)의 재질은 폴리글리골라이드(PGA), 폴리락틱액시드(PLA), 폴리-L-락타이드(PLLA), 폴리카프로락톤(PCL), 폴리다이옥사논(PDO), 금 중에서 선택된 어느 하나 또는 이들의 조합을 통해 형성될 수 있다. The first net 110 is formed long in one direction, it is provided in the form of a tube having a first diameter. Since the first mesh 110 has a plurality of holes, body fluids such as blood may move through the holes even when inserted into the human body. In addition, the shape of the first mesh 110 formed with a plurality of holes may be referred to as a mesh shape. In addition, since the first mesh 110 can secure the maximum cross-sectional area that can be contacted in the human body, it is possible to increase the effect of generating a native material. The first mesh 110 may be made of a material that is harmless to the human body, and if it remains in the body, it may be removed by melting over time. For example, the material of the first mesh 110 is polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL), polydioxane It may be formed through any one selected from the group consisting of PDO, gold, or a combination thereof.
상기 제 1 그물망(110)의 일단에는 고정 단부(111)가 형성된다. 예를 들어, 상기 고정 단부(111)는 상기 제 1 그물망(110)의 일단을 열 압착 방식에 의해 서로 결합된 형태로 형성할 수 있다. 상기 고정 단부(111)는 니들(10)을 통해 리프팅 부재(100)를 체내에 삽입한 뒤 상기 니들(10)을 제거할 때, 상기 리프팅 부재(100)가 니들(10)과 함께 체내로부터 빠지는 것을 방지하는 역할을 한다. 또한, 상기 고정 단부(111)는 체내에서 리프팅 부재(100)의 위치를 고정하는 역할을 한다. A fixed end 111 is formed at one end of the first mesh 110. For example, the fixing end 111 may form one end of the first mesh 110 in a form bonded to each other by a thermocompression bonding method. The fixed end 111 is removed from the body together with the needle 10 when the lifting member 100 is inserted into the body through the needle 10 and then the needle 10 is removed. Serves to prevent this from happening. In addition, the fixing end 111 serves to fix the position of the lifting member 100 in the body.
상기 제 2 그물망(120)은 상기 제 1 그물망(110)의 내측에 위치하며, 일 방향으로 길게 형성되고 제2직경을 갖는 관의 형태로 구비된다. 상기 제 2 그물망(120)은 제 1 그물망(110)과 동일한 길이로 형성되되 제 1 그물망(110)의 제1직경보다 작은 제2직경을 갖는다. 또한, 상기 제 2 그물망(120)은 제 1 그물망(110)에 비해 보다 촘촘하게 형성된다. 상기 제 2 그물망(120)의 일단은 상기 제 1 그물망(110)의 고정 단부(111)에 결합된다. 예를 들어, 상기 제 2 그물망(120)의 일단은 열 압착 방식에 의해 상기 고정 단부(111)에 결합될 수 있다. 따라서, 니들(10)을 통해 리프팅 부재(100)를 체내에 삽입한 뒤 상기 니들(10)을 제거하더라도, 상기 제 2 그물망(120)은 제 1 그물망(110)에 결합된 채 체내에 남아있게 된다. 상기 제 2 그물망(120)은 사람의 체내에서 접촉할 수 있는 단면적을 늘릴 수 있기 때문에, 자생 물질이 생성되는 효과를 높일 수 있다. 상기 제 2 그물망(120)은 인체에 무해한 재질로 이루어질 수 있으며, 체내에 잔존하게 되는 경우 일정 시간이 지남에 따라 녹아서 제거될 수 있다. 예를 들어, 상기 제 2 그물망(120)의 재질은 상기 제 1 그물망(110)과 동일하게 폴리글리골라이드(PGA), 폴리락틱액시드(PLA), 폴리-L-락타이드(PLLA), 폴리카프로락톤(PCL), 폴리다이옥사논(PDO), 금 중에서 선택된 어느 하나 또는 이들의 조합을 통해 형성될 수 있다.The second mesh 120 is located inside the first mesh 110 and is provided in the form of a tube which is formed to be long in one direction and has a second diameter. The second mesh 120 is formed to have the same length as the first mesh 110 but has a second diameter smaller than the first diameter of the first mesh 110. In addition, the second mesh 120 is formed more densely than the first mesh 110. One end of the second mesh 120 is coupled to the fixed end 111 of the first mesh 110. For example, one end of the second mesh 120 may be coupled to the fixed end 111 by a thermal compression method. Therefore, even if the needle 10 is removed after the lifting member 100 is inserted into the body through the needle 10, the second mesh 120 remains in the body coupled to the first mesh 110. do. Since the second mesh 120 can increase the cross-sectional area that can be contacted in the human body, it is possible to increase the effect of generating a native material. The second mesh 120 may be made of a material that is harmless to the human body, and if it remains in the body, it may be removed by melting over time. For example, the material of the second mesh 120 is the same as the first mesh 110, polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), Polycaprolactone (PCL), polydioxanone (PDO), gold may be formed through any one or a combination thereof.
또한, 도 2a에 도시된 바와 같이, 상기 리프팅 부재(100)가 니들에 결합될 때, 상기 제 1 그물망(110)은 니들(10)의 외측에 위치하고 제 2 그물망(120)은 니들(10)의 내측에 위치할 수 있다. 즉, 상기 니들(10)은 제 1 그물망(110)과 제 2 그물망(120) 사이에 끼워지며, 니들(10)의 일단은 상기 고정 단부(111)에 결합된다. 상기 리프팅 부재(100)는 니들(10)에 결합되어 체내에 삽입되고, 상기 니들(10)이 제거됨으로써 상기 리프팅 부재(100)만 체내에 잔존하게 된다. 여기서, 상기 니들(10)은 주사기 등에 결합된 상태에서 상기 리프팅 부재(100)를 체내에 삽입할 수 있고, 주사기로부터 약물 등을 전달받아 리프팅 부재(100)를 통해 인체 내로 주입할 수 있다. Also, as shown in FIG. 2A, when the lifting member 100 is coupled to the needle, the first mesh 110 is located outside the needle 10 and the second mesh 120 is the needle 10. It may be located inside of. That is, the needle 10 is fitted between the first mesh 110 and the second mesh 120, one end of the needle 10 is coupled to the fixed end 111. The lifting member 100 is coupled to the needle 10 and inserted into the body. As the needle 10 is removed, only the lifting member 100 remains in the body. Here, the needle 10 may insert the lifting member 100 into the body while being coupled to a syringe or the like, and receive the drug or the like from the syringe and inject it into the human body through the lifting member 100.
이와 같이, 본 발명의 일 실시예에 따른 리프팅 부재(100)는 이중 그물망 구조(제 1 그물망 및 제 2 그물망을 구비)로 이루어짐으로써, 체내에서 접촉할 수 있는 단면적을 넓혀 자생 물질이 생성되는 효과를 높일 수 있다. 이에 따라, 본 발명의 일 실시예에 따른 리프팅 부재(100)는 치료 또는 미용 효과를 향상시킬 수 있다. As such, the lifting member 100 according to an embodiment of the present invention has a double mesh structure (having a first mesh and a second mesh), thereby widening the cross-sectional area that can be contacted in the body, thereby generating a native material. Can increase. Accordingly, the lifting member 100 according to an embodiment of the present invention can improve the therapeutic or cosmetic effect.
도 3은 본 발명의 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다. 3 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 3을 참조하면, 본 발명의 다른 실시예에 따른 리프팅 부재(200)는 제 1 그물망(110) 및 제 2 그물망(220)을 포함한다. 앞서 설명한 실시예와 동일한 구성 및 동작을 갖는 부분에 대해서는 동일한 도면부호를 붙였으며, 이하에서는 앞의 실시예와의 차이점을 위주로 설명하도록 한다.Referring to FIG. 3, the lifting member 200 according to another embodiment of the present invention includes a first mesh 110 and a second mesh 220. Portions having the same configuration and operation as those of the above-described embodiment are denoted by the same reference numerals, and hereinafter, the differences from the previous embodiment will be mainly described.
상기 제 2 그물망(220)은 상기 제 1 그물망(110)의 내측에 위치하며, 일 방향으로 길게 형성된 관의 형태로 구비된다. 상기 제 2 그물망(220)은 다수개로 이루어지며, 상기 제 1 그물망(110)의 길이와 동일하게 형성된다. 도 3에는 제 2 그물망(220)이 2개로 이루어진 것으로 도시되었으나, 상기 제 2 그물망(220)은 그 이상으로 형성될 수 있다. 여기서, 상기 제 2 그물망(220)의 개수가 많아질수록, 제 2 그물망(220)의 직경은 작아지게 된다. 또한, 제 2 그물망(220)의 일단은 상기 제 1 그물망(110)의 고정 단부(111)에 결합된다. 예를 들어, 상기 제 2 그물망(220)의 일단은 열 압착 방식에 의해 상기 고정 단부(111)에 결합될 수 있다. 따라서, 니들(10)을 통해 리프팅 부재(200)를 체내에 삽입한 뒤 상기 니들(10)을 제거하더라도, 상기 제 2 그물망(220)은 제 1 그물망(110)에 결합된 채 체내에 남아있게 된다. The second mesh 220 is located inside the first mesh 110 and is provided in the form of a tube elongated in one direction. The second net 220 is made of a plurality, is formed to be the same as the length of the first net (110). In FIG. 3, the second mesh 220 is illustrated as two, but the second mesh 220 may be formed in more than one. Here, as the number of the second meshes 220 increases, the diameter of the second meshes 220 becomes smaller. In addition, one end of the second mesh 220 is coupled to the fixed end 111 of the first mesh 110. For example, one end of the second net 220 may be coupled to the fixed end 111 by a thermocompression method. Therefore, even if the needle 10 is removed after the lifting member 200 is inserted into the body through the needle 10, the second mesh 220 remains in the body coupled to the first mesh 110. do.
이와 같이, 본 발명의 다른 실시예에 따른 리프팅 부재(200)는 제 1 그물망(110) 및 다수개의 제 2 그물망(220)을 구비함으로써, 체내에서 접촉하는 단면적을 증가시켜 더 많은 자생 물질을 유도할 수 있다. As such, the lifting member 200 according to another embodiment of the present invention includes the first mesh 110 and the plurality of second meshes 220, thereby increasing the cross-sectional area in contact with the body to induce more native substances. can do.
도 4는 본 발명의 또 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다. 4 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 4를 참조하면, 본 발명의 또 다른 실시예에 따른 리프팅 부재(300)는 제 1 그물망(110), 제 2 그물망(220) 및 중심사(330)를 포함한다.Referring to FIG. 4, the lifting member 300 according to another embodiment of the present invention includes a first mesh 110, a second mesh 220, and a central yarn 330.
상기 중심사(330)는 상기 제 1 그물망(110)의 내측에 위치하며, 상기 제 1 그물망(110)의 길이방향을 따라 직선 형태로 길게 형성된다. 상기 중심사(330)의 일단은 상기 제 1 그물망(110)의 고정 단부(111)와 결합된다. 즉, 상기 중심사(330)는 상기 제 1 그물망(110)의 중심에 위치하며, 일단이 상기 고정 단부(111)에 결합되고 상기 제 1 그물망(110)의 길이방향을 따라서 일직선 형태로 연장된다. 여기서, 상기 제 1 그물망(110)의 일단이 열 압착 방식에 의해 상기 중심사(330)에 결합됨으로써, 상기 고정 단부(111)가 형성될 수 있다. 상기 중심사(330)의 재질은 상기 제 1 그물망(110)과 동일하게 폴리글리골라이드(PGA), 폴리락틱액시드(PLA), 폴리-L-락타이드(PLLA), 폴리카프로락톤(PCL), 폴리다이옥사논(PDO), 금 중에서 선택된 어느 하나 또는 이들의 조합을 통해 형성될 수 있다. The central yarn 330 is located inside the first mesh 110, and is formed to be elongated in a straight line along the longitudinal direction of the first mesh 110. One end of the central yarn 330 is coupled to the fixed end 111 of the first mesh 110. That is, the center yarn 330 is located at the center of the first mesh 110, one end is coupled to the fixed end 111 and extends in a straight line along the longitudinal direction of the first mesh 110. . Here, one end of the first mesh 110 is coupled to the central yarn 330 by a thermal compression method, the fixed end 111 may be formed. The material of the core yarn 330 is polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL) as in the first mesh 110 ), Polydioxanone (PDO), gold, or any combination thereof.
상기 제 2 그물망(320)은 상기 제 1 그물망(110)의 내측에 위치하며, 상기 중심사(330)에 결합된다. 또한, 상기 제 2 그물망(320)은 다수개로 이루어지며, 상기 제 1 그물망(110)의 길이보다 짧게 형성된다. 또한, 상기 제 2 그물망(320)의 일단에는 상기 중심사(330)에 고정 결합되는 결합부(321)가 형성된다. 상기 결합부(321)는 제 2 그물망(320)의 일단을 열 압착 방식으로 상기 중심사(330)에 고정시킴으로써 형성될 수 있다. 즉, 상기 제 2 그물망(320)은 상기 제 1 그물망(110)의 길이보다 짧게 형성되어, 다수개가 상기 중심사(330)에 결합된 채 제 1 그물망(110)의 내측에 위치한다. The second mesh 320 is located inside the first mesh 110 and is coupled to the central yarn 330. In addition, the second net 320 is made of a plurality, it is formed shorter than the length of the first net (110). In addition, a coupling part 321 fixed to the central yarn 330 is formed at one end of the second mesh 320. The coupling part 321 may be formed by fixing one end of the second mesh 320 to the central yarn 330 by a thermocompression bonding method. That is, the second mesh 320 is formed to be shorter than the length of the first mesh 110, a plurality of which is located inside the first mesh 110 while being coupled to the central yarn 330.
더불어, 상기 제 2 그물망(320)은 상기 제 1 그물망(110)의 연장 방향과 반대 방향으로 연장된다. 다시 말해, 상기 중심사(330)를 기준으로, 상기 제 1 그물망(110)은 상기 중심사(330)의 일측에 결합되어 일측에서 타측 방향으로 연장된 반면, 상기 제 2 그물망(320)은 상기 중심사(330)의 타측에 결합되어 타측에서 일측 방향으로 연장되게 형성된다. In addition, the second mesh 320 extends in a direction opposite to the extending direction of the first mesh 110. In other words, based on the central yarn 330, the first mesh 110 is coupled to one side of the central yarn 330 and extends from one side to the other side, while the second mesh 320 is Is coupled to the other side of the central yarn 330 is formed to extend in one direction from the other side.
이러한 리프팅 부재(300)를 체내에 삽입하면, 상기 중심사(330)의 일부는 외부로 노출된다. 이후, 외부에서 사람이 상기 중심사(330)를 잡아 당기더라도, 상기 제 1 그물망(110) 및 제 2 그물망(320)은 체내에서의 저항에 의해 당겨지지 않고 잔존하게 되며 보다 밀집된 형태가 된다. 따라서, 특정 부분에서 더 많은 자생 물질의 생성을 유도할 수 있다.When the lifting member 300 is inserted into the body, a part of the central yarn 330 is exposed to the outside. Then, even if a person pulls the central yarn 330 from the outside, the first net 110 and the second net 320 is not pulled by the resistance in the body and remain more dense form. Thus, it is possible to induce the production of more native substances in certain parts.
도 5는 본 발명의 또 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다. 5 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 5를 참조하면, 본 발명의 또 다른 실시예에 따른 리프팅 부재(400)는 제 1 그물망(410), 제 2 그물망(420) 및 중심사(330)를 포함한다.Referring to FIG. 5, the lifting member 400 according to another embodiment of the present invention includes a first mesh 410, a second mesh 420, and a central yarn 330.
상기 제 1 그물망(410)은 상기 중심사(330)의 일측 단부에 결합되며, 중심사(330)의 일측에서 타측 방향으로 연장되게 형성된다. 상기 제 1 그물망(410)의 일단에는 상기 중심사(330)에 결합되는 고정 단부(411)가 형성된다. 또한, 상기 제 1 그물망(410)은 도 4에 도시된 제 1 그물망(110)에 비해 상대적으로 길이가 짧게 형성된 형태이다. The first net 410 is coupled to one end of the central yarn 330, is formed to extend in one direction from one side of the central yarn 330. One end of the first mesh 410 is formed with a fixed end 411 is coupled to the central yarn 330. In addition, the first mesh 410 is formed in a relatively short length compared to the first mesh 110 shown in FIG.
상기 제 2 그물망(420)은 상기 중심사(330)의 타측에 결합되며, 중심사(330)의 타측에서 일측 방향으로 연장되게 형성된다. 즉, 상기 제 2 그물망(420)은 상기 제 1 그물망(410)의 연장 방향과 반대 방향으로 연장된다. 상기 제 2 그물망(420)의 일단에는 상기 중심사(330)에 고정 결합되는 결합부(421)가 형성된다. 또한, 상기 제 2 그물망(420)은 상기 제 1 그물망(410)과 이격되게 형성된다. 다시 말해, 상기 제 2 그물망(420)의 직경은 상기 제 1 그물망(410)의 직경 보다 작지만, 상기 제 1 그물망(410)의 내측에 위치하지는 않는다. The second net 420 is coupled to the other side of the central yarn 330, is formed to extend in one direction from the other side of the central yarn 330. That is, the second mesh 420 extends in the direction opposite to the extending direction of the first mesh 410. One end of the second net 420 is formed with a coupling portion 421 is fixedly coupled to the central yarn 330. In addition, the second mesh 420 is formed to be spaced apart from the first mesh 410. In other words, the diameter of the second mesh 420 is smaller than the diameter of the first mesh 410, but is not located inside the first mesh 410.
도 6은 본 발명의 또 다른 실시예에 따른 리프팅 부재를 도시한 단면도이다. 6 is a cross-sectional view showing a lifting member according to another embodiment of the present invention.
도 6을 참조하면, 본 발명의 또 다른 실시예에 따른 리프팅 부재(500)는 제 1 그물망(410), 제 2 그물망(520) 및 중심사(330)를 포함한다.Referring to FIG. 6, the lifting member 500 according to another embodiment of the present invention includes a first mesh 410, a second mesh 520, and a central yarn 330.
상기 제 2 그물망(520)은 상기 중심사(330)의 타측에 결합되며, 중심사(330)의 타측에서 일측 방향으로 연장되게 형성된다. 상기 제 2 그물망(520)의 일단에는 상기 중심사(330)에 고정 결합되는 결합부(521)가 형성된다. 즉, 상기 제 2 그물망(520)은 상기 제 1 그물망(410)의 연장 방향과 반대 방향으로 연장된다. 또한, 상기 제 2 그물망(520)의 일부는 상기 제 1 그물망(410)과 겹쳐지게 형성된다. The second net 520 is coupled to the other side of the central yarn 330, is formed to extend in one direction from the other side of the central yarn 330. One end of the second net 520 is formed with a coupling portion 521 fixedly coupled to the central yarn 330. That is, the second mesh 520 extends in the direction opposite to the extending direction of the first mesh 410. In addition, a portion of the second mesh 520 is formed to overlap with the first mesh 410.
이상에서 설명한 것은 본 발명에 의한 리프팅 부재를 실시하기 위한 하나의 실시예에 불과한 것으로서, 본 발명은 상기한 실시예에 한정되지 않고, 이하의 특허청구범위에서 청구하는 바와 같이 본 발명의 요지를 벗어남이 없이 당해 발명이 속하는 분야에서 통상의 지식을 가진 자라면 누구든지 다양한 변경 실시가 가능한 범위까지 본 발명의 기술적 정신이 있다고 할 것이다.What has been described above is only one embodiment for carrying out the lifting member according to the present invention, and the present invention is not limited to the above-described embodiment, and as claimed in the following claims, it departs from the scope of the present invention. Without this, anyone skilled in the art to which the present invention pertains will have the technical spirit of the present invention to the extent that various modifications can be made.

Claims (11)

  1. 일 방향으로 연장되고 일단에 고정 단부가 형성된 제 1 그물망; 및A first mesh extending in one direction and having a fixed end formed at one end thereof; And
    상기 제 1 그물망의 내측에 위치하고, 상기 고정 단부에 결합된 제 2 그물망을 포함하는 것을 특징으로 하는 리프팅 부재.And a second mesh located inside the first mesh and coupled to the fixed end.
  2. 제 1 항에 있어서,The method of claim 1,
    상기 제 2 그물망은 상기 제 1 그물망의 길이 방향을 따라 연장된 것을 특징으로 하는 리프팅 부재.And said second mesh extends along the longitudinal direction of said first mesh.
  3. 제 1 항에 있어서,The method of claim 1,
    상기 제 1 그물망은 제1직경을 갖는 관의 형태로 형성되고,The first net is formed in the form of a tube having a first diameter,
    상기 제 2 그물망은 상기 제1직경보다 작은 제2직경을 갖는 관의 형태로 형성된 것을 특징으로 하는 리프팅 부재.And said second mesh is formed in the form of a tube having a second diameter less than said first diameter.
  4. 제 1 항에 있어서,The method of claim 1,
    상기 제 2 그물망은 적어도 하나 이상으로 이루어진 것을 특징으로 하는 리프팅 부재.And the second mesh is formed of at least one.
  5. 제 1 항에 있어서,The method of claim 1,
    상기 제 1 그물망 및 제 2 그물망은 폴리글리골라이드(PGA), 폴리락틱액시드(PLA), 폴리-L-락타이드(PLLA), 폴리카프로락톤(PCL), 폴리다이옥사논(PDO), 금 중에서 선택된 어느 하나 또는 이들의 조합을 통해 형성된 것을 특징으로 하는 리프팅 부재.The first and second meshes include polyglycolide (PGA), polylactic acid (PLA), poly-L-lactide (PLLA), polycaprolactone (PCL), polydioxanone (PDO), Lifting member, characterized in that formed through any one selected from gold or a combination thereof.
  6. 일 방향으로 연장된 중심사;A central yarn extending in one direction;
    상기 중심사의 일측에 결합되며, 상기 중심사의 길이 방향을 따라 연장된 제 1 그물망; 및A first mesh coupled to one side of the central yarn and extending in a longitudinal direction of the central yarn; And
    상기 중심사의 타측에 결합되며, 상기 중심사의 길이 방향을 따라 연장된 제 2 그물망을 포함하는 것을 특징으로 하는 리프팅 부재.A lifting member coupled to the other side of the central yarn, comprising a second net extending in the longitudinal direction of the central yarn.
  7. 제 6 항에 있어서,The method of claim 6,
    상기 제 1 그물망은 상기 중심사의 일측에서 타측 방향으로 연장되고,The first net is extended from one side of the central yarn in the other direction,
    상기 제 2 그물망은 상기 중심사의 타측에서 일측 방향으로 연장된 것을 특징으로 하는 리프팅 부재.The second net is a lifting member, characterized in that extending in one direction from the other side of the central yarn.
  8. 제 6 항에 있어서,The method of claim 6,
    상기 제 1 그물망은 제1직경을 갖는 관의 형태로 형성되고,The first net is formed in the form of a tube having a first diameter,
    상기 제 2 그물망은 상기 제1직경보다 작은 제2직경을 갖는 관의 형태로 형성된 것을 특징으로 하는 리프팅 부재.And said second mesh is formed in the form of a tube having a second diameter less than said first diameter.
  9. 제 6 항에 있어서,The method of claim 6,
    상기 제 2 그물망은 적어도 하나 이상으로 이루어진 것을 특징으로 하는 리프팅 부재.And the second mesh is formed of at least one.
  10. 제 6 항에 있어서,The method of claim 6,
    상기 제 2 그물망의 적어도 일부는 상기 제 1 그물망의 내측에 위치하는 것을 특징으로 하는 리프팅 부재.And at least a portion of the second net is located inside the first net.
  11. 제 6 항에 있어서,The method of claim 6,
    상기 제 2 그물망은 상기 제 1 그물망과 이격된 것을 특징으로 하는 리프팅 부재.And the second net is spaced apart from the first net.
PCT/KR2017/011108 2017-06-05 2017-10-10 Lifting member WO2018225898A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0069639 2017-06-05
KR1020170069639A KR101905162B1 (en) 2017-06-05 2017-06-05 Lifting Device

Publications (1)

Publication Number Publication Date
WO2018225898A1 true WO2018225898A1 (en) 2018-12-13

Family

ID=63864536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/011108 WO2018225898A1 (en) 2017-06-05 2017-10-10 Lifting member

Country Status (2)

Country Link
KR (1) KR101905162B1 (en)
WO (1) WO2018225898A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102604078B1 (en) * 2023-01-20 2023-11-20 주식회사 엠베이스 Medical lifting thread including mesh

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540051A (en) * 2007-09-26 2010-12-24 エシコン・インコーポレイテッド Self-fixing tissue lifting device and method of manufacturing the device
KR101155817B1 (en) * 2011-10-31 2012-06-12 김종우 Implant for tissue lifting
KR101192308B1 (en) * 2012-02-23 2012-10-17 구태훈 Mesh for soft tissue repair
WO2015012707A1 (en) * 2013-07-25 2015-01-29 Bartłomiej Iwańczyk Resorbable expanding mesh implant partially capped with a barrier membrane
KR101635580B1 (en) * 2014-12-03 2016-07-20 김근식 Mesh Type Lifting Device
KR20170029444A (en) * 2017-02-23 2017-03-15 주식회사 지엠디 Three dimensional shaped lifting mesh

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101729187B1 (en) 2016-09-06 2017-04-21 김동진 Mesh Assembly For Plastic Operation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540051A (en) * 2007-09-26 2010-12-24 エシコン・インコーポレイテッド Self-fixing tissue lifting device and method of manufacturing the device
KR101155817B1 (en) * 2011-10-31 2012-06-12 김종우 Implant for tissue lifting
KR101192308B1 (en) * 2012-02-23 2012-10-17 구태훈 Mesh for soft tissue repair
WO2015012707A1 (en) * 2013-07-25 2015-01-29 Bartłomiej Iwańczyk Resorbable expanding mesh implant partially capped with a barrier membrane
KR101635580B1 (en) * 2014-12-03 2016-07-20 김근식 Mesh Type Lifting Device
KR20170029444A (en) * 2017-02-23 2017-03-15 주식회사 지엠디 Three dimensional shaped lifting mesh

Also Published As

Publication number Publication date
KR101905162B1 (en) 2018-10-08

Similar Documents

Publication Publication Date Title
FitzGerald et al. A regenerative microchannel neural interface for recording from and stimulating peripheral axons in vivo
WO2011162511A2 (en) Tube-type medical needle unit and method of inserting plurality of medical sutures into tube-type medical needle
JP6761057B2 (en) Suture for lifting and its manufacturing method
KR101635580B1 (en) Mesh Type Lifting Device
CN108136194A (en) Clothes used in wearable medical treatment device
CA2425224A1 (en) Health monitoring
Farina et al. Multichannel thin-film electrode for intramuscular electromyographic recordings
CN104023787A (en) Sensing or stimulating activity of tissue
WO2013168995A1 (en) Wrinkle removing implant
WO2021054792A1 (en) Lifting thread with stretchable variable portion
WO2018225898A1 (en) Lifting member
CN105142719A (en) Device and methods for targeted tissue drug delivery
Nazari et al. Regional variation in cholinergic terminal activity determines the non-uniform occurrence of cortical slow waves during REM sleep in mice
CN104941065A (en) Implanted type electrical nerve stimulation system and protection sleeve applied to same
WO2024058498A1 (en) Low-intensity non-invasive focused ultrasound system for deep brain stimulation
Morganti et al. Skin delivery and controlled release of active ingredients nanoencapsulated by chitin nanofibrils: A new approach
WO2019245319A1 (en) Medical thread device
US9555235B2 (en) Multi-layered micro-channel electrode array with regenerative selectivity
DE102018101561B3 (en) An electrically conductive yarn for garment electrodes, garment and method of making an electrically conductive garment for garments for stimulation and data collection of body areas
GB2350193A (en) Health monitoring garment
WO2019093555A1 (en) Cone-type tubular suture and needle assembly incorporating same
EP3088046B1 (en) Implantable spacer
EP3634566B1 (en) Compression garment for providing neuromuscular electrical stimulation
CN204890959U (en) Neural electro photoluminescence system of implanted and be applied to protective sheath of neural electro photoluminescence system of this implanted
WO2019066122A1 (en) Tubular multi-suture thread coupling kit

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17912593

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17912593

Country of ref document: EP

Kind code of ref document: A1